Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants
Journal of Clinical Investigation · 15.04.2024 · 134 (8)
DOI: 10.1172/jci174439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 14.03.2024. Verfasst von Mengfei Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: COVID-19, Common Cold. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDCD NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
SARS-CoV-2 infection of the upper airway and the subsequent immune response are early, critical factors in COVID-19 pathogenesis. By studying infection of human biopsies in vitro and in a hamster model in vivo, we demonstrated a transition in nasal tropism from olfactory to respiratory epithelium as the virus evolved. Analyzing each variant revealed that SARS-CoV-2 WA1 or Delta infect a proportion of olfactory neurons in addition to the primary target sustentacular cells. The Delta variant possessed broader cellular invasion capacity into the submucosa, while Omicron displayed enhanced nasal respiratory infection and longer retention in the sinonasal epithelium. The olfactory neuronal infection by WA1 and the subsequent olfactory bulb transport via axon were more pronounced in younger hosts. In addition, the observed viral clearance delay and phagocytic dysfunction in aged olfactory mucosa were accompanied by a decline of phagocytosis-related genes. Further, robust basal stem cell activation contributed to neuroepithelial regeneration and restored ACE2 expression postinfection. Together, our study characterized the nasal tropism of SARS-CoV-2 strains, immune clearance, and regeneration after infection. The shifting characteristics of viral infection at the airway portal provide insight into the variability of COVID-19 clinical features, particularly long COVID, and may suggest differing strategies for early local intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Baltimore, Maryland, USA.
- Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Förderung
- NIAID NIH HHS
- NIDCD NIH HHS
- National Institutes of Health
Zitieren
APA
Chen, M., Pekosz, A., Villano, J. S., Shen, W., Zhou, R., Kulaga, H., Li, Z., Smith, A., Gurung, A., Beck, S. E., Witwer, K. W., Mankowski, J. L., Ramanathan, M., Rowan, N. R., & Lane, A. P. (2024). Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants. Journal of Clinical Investigation, 134(8). https://doi.org/10.1172/jci174439
Vancouver
Chen M, Pekosz A, Villano JS, Shen W, Zhou R, Kulaga H, et al. Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants. Journal of Clinical Investigation. 2024;134(8). doi:10.1172/jci174439
BibTeX
@article{Chen2024,
author = {Chen, Mengfei and Pekosz, Andrew and Villano, Jason S and Shen, Wenjuan and Zhou, Ruifeng and Kulaga, Heather and Li, Zhexuan and Smith, Amy and Gurung, Asiana and Beck, Sarah E and Witwer, Kenneth W and Mankowski, Joseph L and Ramanathan, Murugappan and Rowan, Nicholas R and Lane, Andrew P},
title = {Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {8},
doi = {10.1172/jci174439}
}
EUVIMED